Filip S Ekholm Selected Research

monomethylauristatin F

1/2021	Halogenation at the Phenylalanine Residue of Monomethyl Auristatin F Leads to a Favorable cis/trans Equilibrium and Retained Cytotoxicity.
1/2019	Increasing the Potential of the Auristatin Cancer-Drug Family by Shifting the Conformational Equilibrium.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Filip S Ekholm Research Topics

Disease

7	Neoplasms (Cancer) 01/2021 - 11/2016
1	Dry Eye Syndromes (Dry Eye Syndrome) 01/2019
1	Sepsis (Septicemia) 01/2014

Drug/Important Bio-Agent (IBA)

5	Immunoconjugates (Immunoconjugate)IBA 01/2021 - 11/2016
3	Cytotoxins (Cytolysins)IBA 01/2021 - 01/2019
2	monomethylauristatin FIBA 01/2021 - 01/2019
2	Pharmaceutical PreparationsIBA 01/2019 - 11/2016
2	Biological ProductsIBA 01/2019 - 01/2014
1	SolutionsIBA 01/2021
1	BoronIBA 01/2021
1	monomethyl auristatin EIBA 01/2019
1	auristatinIBA 01/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2019
1	LipidsIBA 01/2019
1	AntibodiesIBA 11/2016

Therapy/Procedure

2	Boron Neutron Capture Therapy 01/2021 - 10/2020
1	Therapeutics 01/2021